Sol-Gel Technologies (SLGL) EBIT Margin (2018 - 2026)
Sol-Gel Technologies' (SLGL) quarterly EBIT Margin came in at 3569.44% in Q1 2026, up 268981.0% year-on-year from N/an in Q1 2025, and up 828.33% on a QoQ basis from 490.09% in Q4 2025.
Sol-Gel Technologies (SLGL) EBIT Margin (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 9 years of EBIT Margin data on file, last reported at 3569.44% in Q1 2026.
- On a quarterly basis, EBIT Margin rose 268981.0% year-over-year to 3569.44% in Q1 2026; TTM through Mar 2026 was 29.17%, a 195.0% decrease from a year earlier, with the FY2025 full-year figure at 38.88%, up 6525.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 3569.44%, up from 490.09% in the prior quarter.
- Over the last five years, EBIT Margin for SLGL reached as high as 3569.44% in Q1 2026 and fell as low as 6205.0% in Q4 2022.
- Historically, EBIT Margin has averaged 838.49% across 5 years, with a median of 490.09% in 2025.
- Across the five-year window, EBIT Margin tumbled 627208 bps in 2022 and soared 499538 bps in 2023, its largest moves.
- Year by year, EBIT Margin stood at 6205.0% in 2022, then surged by 81 bps to 1209.62% in 2023, then sank by 81 bps to 2193.88% in 2024, then soared by 78 bps to 490.09% in 2025, then surged by 828 bps to 3569.44% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 3569.44% in Q1 2026, 490.09% in Q4 2025, and 1572.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 3,569.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,569.44% |
| Dec 31, 2025 | -490.09% |
| Sep 30, 2025 | -1,572.00% |
| Jun 30, 2025 | 65.06% |
| Mar 31, 2025 | 879.63% |
| Dec 31, 2024 | -2,193.88% |
| Sep 30, 2024 | -15.44% |
| Jun 30, 2024 | 29.89% |
| Dec 31, 2023 | -1,209.62% |
| Sep 30, 2023 | -2,961.03% |
| Jun 30, 2023 | -1,098.82% |
| Dec 31, 2022 | -6,205.00% |
| Sep 30, 2022 | -1,388.89% |
| Jun 30, 2022 | 13.16% |
| Mar 31, 2022 | 0.20% |
| Dec 31, 2021 | 67.08% |
| Sep 30, 2021 | 95.21% |
| Jun 30, 2021 | 866.59% |
| Mar 31, 2021 | 602.57% |
| Dec 31, 2020 | -324.99% |